PALS Provider: Course

Incorrect. Hyperglycemia is not listed as one of the reversible causes of cardiac arrest (H's and T's).

Incorrect. During CPR with an advanced airway, providing 10 breaths per minute prevents hyperventilation and ensures adequate oxygenation.

Incorrect. Oxygenation and ventilation are the first-line treatments for pediatric bradycardia, addressing the most common cause: hypoxia.

Incorrect. In cardiogenic shock, smaller fluid boluses of 5-10 mL/kg are preferred to avoid fluid overload and worsening cardiac function.

Incorrect. Pediatric defibrillation starts at 2 J/kg and may increase to 4 J/kg for subsequent shocks if needed.

Incorrect. Intraosseous access is a fast and reliable method for drug delivery when IV access is not immediately available.

Incorrect. The recommended compression depth for children is 1/3 the depth of the chest, which is approximately 2 inches.

Incorrect. Lidocaine should not exceed a total dose of 3 mg/kg to avoid toxicity during pediatric resuscitation.

Incorrect. The total fluid bolus dose should not exceed 60 mL/kg to avoid fluid overload during resuscitation in children.

Incorrect. Early administration of epinephrine within 2 minutes improves outcomes in pediatric cardiac arrest.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes, stabilizing cardiac cells and correcting QT prolongation.

Incorrect. Epinephrine is given at a dose of 0.01 mg/kg IV every 3-5 minutes for pediatric bradycardia unresponsive to oxygenation.

Incorrect. Respiratory failure is the leading cause of cardiac arrest in children due to their dependency on oxygenation and ventilation.

Incorrect. Neonatal CPR prioritizes ventilation due to respiratory causes of arrest, using a 3:1 compression-to-ventilation ratio.

Incorrect. Pulse checks should be limited to 10 seconds to minimize interruptions in chest compressions.

Incorrect. Oxygenation and ventilation are the first-line treatments for bradycardia caused by hypoxia; lidocaine is used for arrhythmias.

Incorrect. Epinephrine is given every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Rescue breaths provide adequate oxygenation and ventilation, preventing cardiac arrest in children with respiratory failure.

Incorrect. Fluids restore perfusion, and antibiotics treat the underlying infection causing septic shock.

Incorrect. Immediate defibrillation is crucial to restoring a perfusing rhythm in shockable cardiac arrest.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. Oxygen saturation gradually increases after birth, with a target of 60-65% during the first minute of neonatal resuscitation.

Incorrect. The maximum single dose of adenosine for terminating SVT in pediatric patients is 12 mg, administered as a rapid IV push.

Incorrect. Rescuer roles should be rotated every 2 minutes to prevent fatigue and maintain effective chest compressions.

Incorrect. The correct compression depth for infants is 1/3 the depth of the chest, approximately 1.5 inches.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes during pediatric cardiac arrest to improve perfusion.

Incorrect. Neonates transition to higher oxygen saturation levels gradually, targeting 80-85% by 5 minutes of life.

Incorrect. Compressions for children should be performed with the heel of one or both hands, depending on the child's size.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. The defibrillation dose increases to 4 J/kg for refractory VF after the initial 2 J/kg shock.

Incorrect. Synchronized cardioversion begins at 0.5-1 J/kg for pediatric SVT and increases as needed based on clinical response.

Incorrect. Intramuscular epinephrine is the first-line treatment for pediatric anaphylaxis, administered into the mid-thigh.

Incorrect. ROSC (Return of Spontaneous Circulation) indicates the restoration of effective blood flow with a detectable pulse.

Incorrect. Tension pneumothorax is a treatable cause of cardiac arrest, managed by needle decompression to relieve intrathoracic pressure.

Incorrect. Vagal maneuvers are used to terminate stable SVT by increasing parasympathetic stimulation to the AV node.

Incorrect. Epinephrine is administered to improve perfusion and increase heart rate in bradycardia unresponsive to oxygenation.

Incorrect. Limiting fluid boluses to 10 mL/kg prevents fluid overload and worsening cardiac function in cardiogenic shock.

Incorrect. The total cumulative dose of amiodarone during pediatric cardiac arrest should not exceed 15 mg/kg.

Incorrect. Defibrillation is the primary treatment for shockable rhythms like ventricular fibrillation or pulseless VT.

Incorrect. Oxygen is administered to stabilize respiratory failure and improve oxygen delivery.

Incorrect. Oxygen improves perfusion and is the first-line treatment for bradycardia caused by hypoxia.

Incorrect. A fluid bolus, typically 20 mL/kg of isotonic crystalloid, is the first step in treating hypovolemic shock in children.

Incorrect. By 10 minutes after birth, neonates should reach an oxygen saturation of 90-95%, reflecting effective oxygenation.

Incorrect. Lidocaine is used as an antiarrhythmic in cardiac arrest, with a cumulative dose limit of 3 mg/kg.

Incorrect. Amiodarone is given at 5 mg/kg IV/IO for ventricular tachycardia with a pulse to stabilize the rhythm.

Incorrect. Asystole is a non-shockable rhythm requiring immediate CPR and epinephrine administration.

Incorrect. Providing 10 breaths per minute ensures adequate oxygenation without causing hyperventilation during CPR with an advanced airway.

Incorrect. Respiratory failure leads to hypoxia, which is the most frequent cause of bradycardia in children.

Incorrect. ROSC refers to the restoration of spontaneous cardiac activity with a detectable pulse and effective circulation.

Incorrect. A 15:2 ratio improves oxygenation and circulation during high-quality infant CPR with two rescuers.

Incorrect. Epinephrine is administered at 0.01 mg/kg IV/IO every 3-5 minutes during pediatric cardiac arrest.

Incorrect. Fowler’s position (sitting upright) helps reduce respiratory effort and improve ventilation in children with breathing difficulties.

Incorrect. Magnesium sulfate is the drug of choice for stabilizing cardiac cells in torsades de pointes.

Incorrect. The two-thumb encircling technique ensures effective chest compressions and promotes better blood flow in infants.

Incorrect. The jaw thrust maneuver protects the cervical spine while ensuring an open airway for effective ventilation.

Incorrect. Hypoxia-induced bradycardia is treated with oxygen to improve oxygenation and perfusion.

Incorrect. Delivering 8-10 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. A bolus of 20 mL/kg isotonic crystalloid restores perfusion in hypovolemic shock.

Incorrect. The first defibrillation dose for pediatric pulseless VT starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks.

Incorrect. Hypothermia is one of the "H's" in reversible causes of cardiac arrest and is treated with active rewarming.

Incorrect. Hypothermia is one of the "H's" and should be corrected to restore normal cardiac function during resuscitation.

Incorrect. The cumulative maximum dose of amiodarone in pediatric cardiac arrest is 15 mg/kg IV/IO, given in divided doses.

Incorrect. Intraosseous access is a fast and reliable method for drug and fluid administration when IV access is not immediately available.

Incorrect. Nebulized epinephrine reduces airway swelling and improves airflow in children with severe croup.

Incorrect. Compressing to one-third the depth of the chest ensures effective perfusion without causing injury during infant CPR.